Table 3 Weighted multiple linear regressions* analysis of predictive factors of HPV-vaccination uptake rate (VUR) and D3-D1 vaccination adherence (VA), Gardasil Access Program, 2009–2013 (N = 21 programs)
From: Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009–2013
Vaccine uptake rate | D3-D1 vaccination adherence | |||||
|---|---|---|---|---|---|---|
β coefficient | 95% CI | p | β coefficient | 95% CI | p | |
Managing institution | ||||||
MoH | Ref | Ref | ||||
NGO | 14.58 | 7.64 to 21.52 | < 10-3 | 3.90 | -2.98 to 10.78 | 0.24 |
Number of sites of vaccination | 0.01 | -0.009 to 0.34 | 0.23 | 0.009 | -0.01 to 0.03 | 0.41 |
Duration of the vaccination program Vaccination delivery model | -1.37 | -2.22 to -0.62 | 0.03 | -1.01 | -1.98 to 0.45 | 0.07 |
Mixed | Ref | Ref | ||||
Health clinic | 13.51 | 1.46 to 25.57 | 0.03 | 3.68 | -8.28 to15.63 | 0.66 |
School | 13.35 | 6.10 to 20.61 | 0.001 | 3.00 | -4.20 to 10.20 | 0.89 |